Section one: Contracting authority
one.1) Name and addresses
MHRA
10 South Colonnade, Canary Wharf
London
E14 4PU
Country
United Kingdom
NUTS code
UKI31 - Camden and City of London
Internet address(es)
Main address
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
Buyer's address
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://health-family.force.com/s/Welcome
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be submitted to the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
National or federal Agency/Office
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Purchase of a Nanoparticle Flow Cytometer
Reference number
C244466
two.1.2) Main CPV code
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
two.1.3) Type of contract
Supplies
two.1.4) Short description
The Agency is looking for a nanoparticle flow cytometer capable of detecting biological particles such as extracellular vesicles, lipid nanoparticles, viruses and other biological nanoparticles when fluorescently labelled or not.
The Technical requirements for purchase of nanoparticle flow cytometer will heavily rely on ability of the instrumentation to deliver high level sensitivity for submicron particles. The equipment in question will be supporting many high-profile projects across the Agency, including adequate sizing and quantification of viral particles, viruses, secretome vesicles, phage, and NLPs. Therefore, it is important to put maximal emphasis on the Scientific and Technical ability (65% of overall marking) of the equipment to deliver very sensitive readouts rather than the Commercial value of this project.
two.1.5) Estimated total value
Value excluding VAT: £200,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 51430000 - Installation services of laboratory equipment
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
Medicines and Healthcare Products Regulatory Agency
Blanche Lane
South Mimms
Potters Bar
Hertfordshire
EN6 3QG
two.2.4) Description of the procurement
The Agency is looking for a nanoparticle flow cytometer capable of detecting biological particles such as extracellular vesicles, lipid nanoparticles, viruses and other biological nanoparticles when fluorescently labelled or not.
The Technical requirements for purchase of nanoparticle flow cytometer will heavily rely on ability of the instrumentation to deliver high level sensitivity for submicron particles. The equipment in question will be supporting many high-profile projects across the Agency, including adequate sizing and quantification of viral particles, viruses, secretome vesicles, phage, and NLPs. Therefore, it is important to put maximal emphasis on the Scientific and Technical ability (65% of overall marking) of the equipment to deliver very sensitive readouts rather than the Commercial value of this project.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £185,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
60
This contract is subject to renewal
Yes
Description of renewals
We expect to award a contract for a one of purchase of the equipment. For service maintenance and/or purchase of any bespoke kits/consumables and/or any IT related requirements, if applicable, the contract will be for the life of the equipment.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
20 May 2024
Local time
10:00am
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 6 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
20 May 2024
Local time
10:00am
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.3) Additional information
This procurement exercise is being run via the Health Family ‘Atamis’ e-tendering
portal: Welcome (site.com)
six.4) Procedures for review
six.4.1) Review body
MHRA/ NIBSC
EN6 3QG
London
EN6 3QG
Country
United Kingdom
Internet address
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency